Metropolitan Life Insurance CO 9 Meters Biopharma, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.85 - $1.33 $54,513 - $85,296
-64,133 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$1.03 - $1.41 $66,056 - $90,427
64,133 New
64,133 $83,000
Q3 2021

Mar 30, 2023
BUY
$1.03 - $1.41 $66,056 - $90,427
64,133 New
64,133 $83,000
Q3 2021

Nov 15, 2021
BUY
$1.03 - $1.41 $66,056 - $90,427
64,133 New
64,133 $83,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email